Edition:
United States

Evoke Pharma Inc (EVOK.OQ)

EVOK.OQ on NASDAQ Stock Exchange Capital Market

2.69USD
3:59pm EST
Change (% chg)

$0.04 (+1.51%)
Prev Close
$2.65
Open
$2.67
Day's High
$2.72
Day's Low
$2.67
Volume
3,405
Avg. Vol
43,486
52-wk High
$4.54
52-wk Low
$1.43

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.342
Jun '17 0.00 -0.106
Mar '17 0.00 -0.373
FY 2016 Dec '16 0.00 -0.124
Sep '16 0.00 -0.285
Jun '16 0.00 -0.412
Mar '16 0.00 -0.450
FY 2015 Dec '15 0.00 -0.368
Sep '15 0.00 -0.421
Jun '15 0.00 -0.522
Mar '15 0.00 -0.577
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 4 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Year Ending Dec-17 4 0.00 0.00 0.00 0.00
Year Ending Dec-18 5 15.16 75.80 0.00 18.95
Earnings (per share)
Quarter Ending Dec-17 5 -0.23 -0.18 -0.26 -0.18
Quarter Ending Mar-18 3 -0.14 -0.10 -0.17 --
Year Ending Dec-17 5 -0.99 -0.85 -1.06 -0.71
Year Ending Dec-18 5 -0.21 1.16 -0.66 -0.06
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.13 35.51
P/E High - Last 5 Yrs. -- 40.67 45.27
P/E Low - Last 5 Yrs. -- 23.64 24.24
Beta 1.12 0.92 0.91
Price to Sales (TTM) -- 3.92 5.83
Price to Book (MRQ) 19.83 4.88 5.68
Price to Tangible Book (MRQ) 19.83 5.74 7.26
Price to Cash Flow (TTM) -- 23.07 24.44
% Owned Institutions 32.75 0.85 1.39

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.49
Dividend Yield - 5 Year Avg -- 2.17 2.05
Dividend 5 Year Growth Rate -- 4.28 5.23
Payout Ratio(TTM) -- 47.28 45.95

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 6.31 6.82
Sales (TTM) vs TTM 1 Yr. Ago -- 5.18 5.65
Sales - 5 Yr. Growth Rate -- 10.02 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -19.83 7.15 7.23
EPS (TTM) vs TTM 1 Yr. Ago 37.62 -- --
EPS - 5 Yr. Growth Rate -- 9.89 10.90
Capital Spending - 5 Yr. Growth Rate -- 15.17 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.49 2.54
Current Ratio (MRQ) 4.06 3.51 3.56
LT Debt to Equity (MRQ) 0.00 10.90 13.23
Total Debt to Equity (MRQ) 0.00 17.04 19.24
Interest Coverage (TTM) -31.54 49.98 44.55

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.14 54.80
Gross Margin - 5 Yr. Avg. -- 52.29 52.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.39 15.52
Operating Margin (TTM) -- 14.77 6.76
Operating Margin - 5 Yr. Avg. -- 14.38 11.03
Pre-Tax Margin (TTM) -- 15.22 7.58
Pre-Tax Margin - 5 Yr. Avg. -- 14.69 11.44
Net Profit Margin (TTM) -- 11.39 3.81
Net Profit Margin - 5 Yr. Avg. -- 11.02 7.73
Effective Tax Rate (TTM) -- 24.35 24.25
Effective Tax Rate - 5 Yr. Avg. -- 23.46 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 952,857,028 858,823,705
Net Income/Employee (TTM) -1,921,201 111,290,090 100,224,560
Receivable Turnover (TTM) -- 5.92 6.12
Inventory Turnover (TTM) -- 2.73 3.55
Asset Turnover (TTM) 0.00 1.00 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -124.68 11.89 11.35
Return on Assets - 5 Yr. Avg. -74.54 12.90 12.32
Return on Investment (TTM) -150.16 15.10 14.47
Return on Investment - 5 Yr. Avg. -86.15 16.88 16.13
Return on Equity (TTM) -397.72 16.59 16.06
Return on Equity - 5 Yr. Avg. -565.58 17.87 17.32
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 38.41 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Evoke Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 32.75%
# of Holders: 30
Total Shares Held: 5,047,895
3 Mo. Net Change: 122,789
# New Positions: 5
# Closed Positions: 4
# Increased Positions: 10
# Reduced Positions: 5
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.